A mutation in the propeptide of factor IX leads to warfarin sensitivity by a novel mechanism

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1619-1625

  Chu, Kirk ^a   Wu, Sheue Mei ^b   Stanley, Tom ^b   Stafford, Darrel W ^b   High, Katherine A ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Factor IX; propeptide; vitamin K; warfarin sensitivity; glutamylcarboxylase

Indexed keywords

BLOOD CLOTTING FACTOR 9; OSTEOCALCIN; VITAMIN K DEPENDENT CARBOXYLASE; VITAMIN K GROUP; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING; CASE REPORT; HEMOSTASIS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029839951     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118956     Document Type: Article

References (25)

1. Stitt, T.N., G. Conn, M. Gore, C. Lai, J. Bruno, C. Radziejewski, K. Mattsson, J. Fisher, D.R. Gies, P.F. Jones et al. 1995. The anticoagulation factor protein S and its relative. Gas6 are ligands for the Tyro 3/Ax1 family of receptor tyrosine kinases. Cell. 80:661-670.
2. Suttie, J.W. 1993. Synthesis of vitamin K-dependent proteins. FASEB J. 7:445-452.
3. Jorgensen, M.J., A.B. Cantor, B.C. Furie, C.L. Brown, C.B. Shoemaker, and B. Furie. 1987. Recognition site directing vitamin K-dependent γ-carboxylation resides on the propeptide of factor IX. Cell. 48:185-191.
4. Knobloch, J.E., and J.W. Suttie. 1987. Vitamin K-dependent carboxylase. Control of enzyme activity hy the "propeptide" region of factor X. J. Biol. Chem. 262:15334-15337.
5. Rabiet, M.J., M.J. Jorgensen, B. Furie, and B.C. Furie. 1987. Effect of propeptide mutations on post-translational processing of factor IX. J. Biol. Chem. 262:14895-14898.
6. Wu, S.-M., B.A.M. Soute, C. Vermeer, and D.W. Stafford. 1990. In vitro gamma-carboxylation of a 59-residue recombinant peptide including the propeptide and the gamma-carboxyglutamic acid domain of coagulation factor IX. Effect of mutations near the propeptide cleavage site. J. Biol. Chem. 265: 13124-13129.
7. Bell, G.I., J.H. Karam, and W.J. Rutter. 1981. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc. Natl. Acad. Sci. USA. 78: 5759-5763.
8. Saiki, R.K., D.H. Gelfland, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. Mullis, and H.A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (Wash. DC). 239:487-491.
9. Lozier, J.N., D.M. Monroe, S. Stanfield-Oakley, S.-W. Lin, K.J. Smith, H.R. Roberts, and K.A. High. 1990. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia. Blood. 75:1097-1104.
10. Horton, R.M., H.D. Hunt, S.N. Ho, J.K. Pullen, and L.R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (Amst.). 77:61-69.
11. Pan, L.C., and P.A. Price. 1985. The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc. Natl. Acad Sci. USA. 82:6109-6113.
12. Price, P.A., and Y. Kaneda. 1987. Vitamin K counteracts the effect of warfarin in liver but not in bone. Thrombosis Res. 46:121-131.
13. Yoshitake, S., B.C. Schach, D.C. Foster, E.W. Davie, and K. Kurachi. 1985. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry. 24:3736-3750.
14. Morris, D.P., B.A.M. Soute, C. Vermeer, and D.W. Stafford. 1993. Characterization of the purified vitamin K-dependent γ-glutamyl carboxylase. J. Biol. Chem. 268:8735-8742.
15. Giannelli, F., P.M. Green, S.S. Sommer, M.C. Poon, M. Ludwig, R. Schwaab, P.H. Reitsma, M. Goossens, A. Yoshioka, and G.G. Brownlee. 1996. Haemophilia B (sixth edition): a database of point mutations and short additions and deletions. Nucleic Acids Res. 24:103-118.
16. Cheung, A., J.W. Suttie, and M. Bernatowicz. 1990, Vitamin K-dependent carboxylase: structural requirements for propeptide activation. Biochimica et Biophysica Acta. 1039:90-93.
17. Soute, B.A., M.M. Ulrich, and C. Vermeer. 1987. Vitamin K-dependent carboxylase: increased efficiency of the carboxylation reaction. Thrombosis & Haemostasis. 57:77-81.
18. Soute, B.A.M., M.M.W. Ulrich, A.D.J. Watson, J.E. Maddison, R.H.M. Ebberink, and C. Vermeer. 1992. Congenital deficiency of all vitamin K-dependent blood coagulation factors due to a defective vitamin K-dependent carboxylase in Devon rex cats. Thrombosis Haemostasis. 68:521-525.
19. Segel, I.H. 1975. Enzyme Kinetics. John Wiley and Sons, Inc., New York. p. 34.
20. de Boer-van den Berg, M.A.G., M.M.W. Ulrich, H.C. Hemker, B.A.M. Soute, and C. Vermeer. 1985. Vitamin K-dependent carboxylase: the carboxylation of exogenous substrates in different systems. Biochim. Biophys. Acta. 831:94-98.
21. Fehrst, A. 1985. Enzyme kinetics. In Enzyme Structure and Mechanisms. W.H. Freeman and Company, New York. p. 112.
22. Morris, D.P., R.D. Stevens, D.J. Wright, and D.W. Stafford. 1995. Processive post-translational modification. J. Biol. Chem. 270:30491-30498.
23. Thompson, A.R. 1977. Factor IX antigen by radioimmunoassay. J. Clin. Invest. 59:900-910.
24. Gillis, S., M. Jacobs, B. Furie, and B.C. Furie. 1995. Properties of the propeptide of Gas6. Blood. 86:79a.
25. Frenette, P.S., T.N. Mayadas, H. Rayburn, R.O. Hynes, and D.D. Wagner. 1996. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell. 84:563-574.